Drugs / Lavandula angustifolia
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06316934 | Jun 2024 → Apr 2025 | anxiety | University of Florida | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lavandula angustifolia | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06316934 ↗ |
| Route | Inhaled | “Lavender essential oil will be placed on paper towel which patient will deeply inhale prior to the start of the procedure.” NCT06316934 ↗ |